Skip to content

Arcolith 3021-Cardiac Pulse Generator

by Arco Medical Products Co.

510(k) K800326

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK800326 Date17 Mar 1980ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Arcolith 3021 Cardiac Pulse Generator is an Implantable Pacemaker Pulse-Generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. This device is classified as a Class III medical device under 21 CFR 870.3610, reflecting its high-risk, life-sustaining nature in cardiovascular applications.

This device is intended for single-use implantation and is regulated under FDA 510(k) clearance (K800326), with a traditional review process through the Cardiovascular (CV) advisory committee. Supplied sterile and intended for surgical implantation, it adheres to MRI safety standards for Class III pacemakers. No additional storage or handling specifications are noted beyond standard sterile surgical protocols.

Other devices from Arco Medical Products Co.

See all devices from Arco Medical Products Co. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Arcolith 3021 Cardiac Pulse Generator, and how does it function in a clinical setting?

    The Arcolith 3021 Cardiac Pulse Generator is designed to regulate cardiac rhythm by delivering controlled electrical impulses to the heart. It functions as an implantable pacemaker, ensuring proper heart function for patients with abnormal heartbeats or conduction issues. This device is intended for single-use implantation and is classified as a high-risk, life-sustaining Class III medical device under FDA regulations.

  • Is the Arcolith 3021 Cardiac Pulse Generator reusable, or is it intended for single-use only?

    The Arcolith 3021 Cardiac Pulse Generator is explicitly intended for single-use implantation only. This is standard for implantable pacemaker pulse-generators to ensure sterility and patient safety, as reuse could compromise device integrity and introduce infection risks.

  • What storage or handling precautions should be taken with the Arcolith 3021 Cardiac Pulse Generator before surgical implantation?

    The device is supplied sterile and must be handled according to standard sterile surgical protocols. No additional storage specifications are noted beyond maintaining its sterile packaging until use. Always follow manufacturer guidelines for unpacking and preparation to prevent contamination.

  • Does the Arcolith 3021 Cardiac Pulse Generator have any compatibility considerations for MRI procedures?

    Yes, the device adheres to MRI safety standards for Class III pacemakers, meaning it is designed to be safe in controlled MRI environments. However, specific MRI compatibility details (e.g., maximum safe field strength) should be verified with the manufacturer’s instructions to avoid interference or damage during imaging.

  • How was the regulatory pathway for the Arcolith 3021 Cardiac Pulse Generator determined, and what does this mean for clinicians?

    The device underwent FDA 510(k) clearance (K800326) through a traditional review process, with input from the Cardiovascular (CV) advisory committee. This means it was deemed *substantially equivalent* to a legally marketed predicate device, ensuring it meets FDA safety and effectiveness standards for implantable pacemakers. Clinicians can rely on this pathway as evidence of rigorous pre-market evaluation.